Correlation Between CENTURIA OFFICE and APELLIS PHARMACTDL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CENTURIA OFFICE and APELLIS PHARMACTDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CENTURIA OFFICE and APELLIS PHARMACTDL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CENTURIA OFFICE REIT and APELLIS PHARMACTDL 0001, you can compare the effects of market volatilities on CENTURIA OFFICE and APELLIS PHARMACTDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CENTURIA OFFICE with a short position of APELLIS PHARMACTDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of CENTURIA OFFICE and APELLIS PHARMACTDL.

Diversification Opportunities for CENTURIA OFFICE and APELLIS PHARMACTDL

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between CENTURIA and APELLIS is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding CENTURIA OFFICE REIT and APELLIS PHARMACTDL 0001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on APELLIS PHARMACTDL 0001 and CENTURIA OFFICE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CENTURIA OFFICE REIT are associated (or correlated) with APELLIS PHARMACTDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of APELLIS PHARMACTDL 0001 has no effect on the direction of CENTURIA OFFICE i.e., CENTURIA OFFICE and APELLIS PHARMACTDL go up and down completely randomly.

Pair Corralation between CENTURIA OFFICE and APELLIS PHARMACTDL

Assuming the 90 days horizon CENTURIA OFFICE REIT is expected to generate 0.48 times more return on investment than APELLIS PHARMACTDL. However, CENTURIA OFFICE REIT is 2.08 times less risky than APELLIS PHARMACTDL. It trades about 0.01 of its potential returns per unit of risk. APELLIS PHARMACTDL 0001 is currently generating about -0.22 per unit of risk. If you would invest  68.00  in CENTURIA OFFICE REIT on November 7, 2024 and sell it today you would earn a total of  0.00  from holding CENTURIA OFFICE REIT or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

CENTURIA OFFICE REIT  vs.  APELLIS PHARMACTDL 0001

 Performance 
       Timeline  
CENTURIA OFFICE REIT 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CENTURIA OFFICE REIT has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, CENTURIA OFFICE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
APELLIS PHARMACTDL 0001 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in APELLIS PHARMACTDL 0001 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, APELLIS PHARMACTDL may actually be approaching a critical reversion point that can send shares even higher in March 2025.

CENTURIA OFFICE and APELLIS PHARMACTDL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CENTURIA OFFICE and APELLIS PHARMACTDL

The main advantage of trading using opposite CENTURIA OFFICE and APELLIS PHARMACTDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CENTURIA OFFICE position performs unexpectedly, APELLIS PHARMACTDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in APELLIS PHARMACTDL will offset losses from the drop in APELLIS PHARMACTDL's long position.
The idea behind CENTURIA OFFICE REIT and APELLIS PHARMACTDL 0001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world